Daniel Arber to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications Daniel Arber has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
0.805
-
Coexistence of inversion 16 and the Philadelphia chromosome in acute and chronic myeloid leukemias : report of six cases and review of literature. Am J Clin Pathol. 2006 Feb; 125(2):260-6.
Score: 0.242
-
Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group study. Int J Lab Hematol. 2020 Aug; 42(4):418-422.
Score: 0.162
-
The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings. Mod Pathol. 1998 Dec; 11(12):1211-21.
Score: 0.147
-
Template for Reporting Results of Monitoring Tests for Patients With Chronic Myelogenous Leukemia (BCR-ABL1(+)). Arch Pathol Lab Med. 2016 Jul; 140(7):672-4.
Score: 0.120
-
Pathology of the myeloproliferative diseases. Hematol Oncol Clin North Am. 2003 Oct; 17(5):1101-27.
Score: 0.051
-
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood. 2003 Jun 15; 101(12):4701-7.
Score: 0.049
-
Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group. Mod Pathol. 2018 05; 31(5):690-704.
Score: 0.035